Latest News

FDA approves non-invasive risdiplam tablet for spinal muscular atrophy | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves non-invasive risdiplam tablet for spinal muscular atrophy

February 12th 2025

The new risdiplam tablet is suitable for those aged 2 years and older who weigh more than 44 lbs, according to Genentech.

A green nail after trauma in an 8-year-old boy | Image credit: Author provided
A green nail after trauma in an 8-year-old boy

February 12th 2025

FDA approves mirdametinib for patients 2 years, older with neurofibromatosis type 1 | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves mirdametinib for patients 2 years, older with neurofibromatosis type 1

February 11th 2025

Direct oral anticoagulants for venous thromboembolism in pediatrics | Image credit: © Artur - © Artur - stock.adobe.com.
Direct oral anticoagulants for venous thromboembolism in pediatrics

February 11th 2025

Atypical presentations of Mycoplasma pneumoniae amid a local outbreak | Image credit: Author provided
Atypical presentations of Mycoplasma pneumoniae amid a local outbreak

February 11th 2025

Latest Videos
Podcasts

All News

© 2025 MJH Life Sciences

All rights reserved.